MENU

3 blue-chip stocks you need to consider

It should come as no surprise, the S&P/ASX 200 Index’s (ASX: XJO) (^AXJO) terrific run in 2013 has left some stocks overvalued. But the big banks aren’t the only ones trading above all-time highs.

In fact unless you’re willing to invest in the resources sector or look for smaller companies listed on the market, there’s not many well-priced companies left to choose. It means we have to work harder to discover where the value lies.

To make it a little easier for you, here are three top companies which are today trading at modest prices.

1. Resmed Inc. (CHESS) (ASX: RMD) is a biotechnology company involved in the manufacturing and distribution of innovative medical products for individuals with respiratory disorders such as sleep apnoea. Listed on both the Australian Stock Exchange (ASX) and New York Stock Exchange (NYSE), ResMed is a truly global company, servicing 100 countries worldwide. It believes around 20% of the adult population suffers from sleep-disordered breathing, but awareness of the issue remains low. ResMed trades on a forward price to earnings of 19 and a dividend yield of 1.9%.

2. Coca-Cola Amatil Ltd (ASX: CCL) has had a rough start to 2014, already falling nearly 22% on the back of poor results and bleak outlooks for near-term earnings. Despite losing share price, CCA is still the same company dealing in the same high quality products. If you believe the company will still be around in 10 years, now could be the time to capitalise on the setback. At current prices it has a forecast 5.4% dividend yield.

3. Telstra Corporation Ltd  (ASX: TLS) is one of Australia’s best dividend stocks. Boasting a market capitalisation of around $65 billion, it is nearly 14 times bigger than its next biggest rival, TPG Telecom Ltd (ASX: TPM). With a 5.5% dividend yield and ongoing growth both domestically and overseas, it could find its way into any portfolio.

Foolish takeaway

The above three companies are priced for long-term success and boast reputable brand names. In addition each have established markets with plenty of room to grow.

The top ASX pick you've never heard of...

Top Motley Fool analysts just identified their #1 ASX pick for 2014, a small-cap stock that could be poised for big gains (and offers a fat, fully franked dividend!). Discover all the details now, including the name and code, in this FREE investment report, "The Motley Fool's Top Stock for 2014."

Motley Fool Contributor Owen Raszkiewicz does not have a financial interest in any of the mentioned companies. 

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.